respiratory_week_2_20190518190046 Flashcards
what is the hallmarks of remodelling in asthma
thickening of basement membrane, collagen deposition of submucosa and hypertrophy of smooth muscle
how to prevent eosinophilic inflammation in asthma
anti-inflammatory medication - corticosteroids, cromones, theophylline
how to prevent release of mediators and TH2 cytokines in asthma
antileukotrienes, antihistamines or mono-clonal antibodies (anti-IgE or anti-interleukin 5)
how to prevent twitchy smooth muscle (hyperactivity) in asthma
bronchodilators (b2 agonists or muscarinic antagonists)
which drugs worsen asthma
NSAIDs e.g. acetylsalicylic acid or b-blockers
what is the associated atopy with asthma
increased IgE e.g. rhinitis, conjunctivitis and eczema
what is blood eosinophilia in asthma
> 3%
how is asthma diagnosed
history, peak flow, FEV1 / FVC <75%, >15% reversibility to salbutamol, testing: exercise or given histamine, metacholine or mannitol
what contributes to COPD
noxious particles e.g. smoking causes inflammation, mucocilliary dysfunction and tissue damage
distinguish between bronchitis and emphysema
bronchitis - wheezing, emphysema - reduced breath sounds
what is the disease process of COPD
1) activated macrophages - release IL-8 and leukotriene B42) neutrophils and macrophages release proteases that break down connective tissue in lung and cause mucus 3) proteases normally counteracted by a1-antitrypsin, SLPI and tissue inhibitors of metric metalloproteinases - appears to be imbalance between protease and antiproteases
what is the chronic cascade in COPD
impaired alveolar gas exchange leads to respiratory failure which leads to pulmonary hypertension (RV hypertrophy or failure)
what is chronic bronchitis
chronic neutrophilic inflammation of bronchi and bronchioles - partially reversible
what is symptoms of chronic bronchitis
cough, clear mucoid sputum, purulent sputum on infection, increasing breathlessness
what is emphysema
alveolar destruction, loss of bronchial support so irreversible
how to assess COPD
degree of airflow limitation, 2 of more exacerbations in last year or FEV1<50% are high risk
what is non-pharmacological COPD management in extreme or rare cases
venesection, lung volume reduction and stenting
what is rarely given pharmacological treatment in COPD
PDE4 inhibitor - roflumilastmucolytic - carbocisteine antibiotics - azithromycin
what is asthma COPD overlap syndrome (ACOS_
COPD with blood eosinophilia >4%, responds better to ICS with regards to exacerbation reduction, more reversible to salbutamol, difficult to distinguish from asthmatic smokers
what are some skeletal causes of disease
thoracic kyphoscoliosis, ankylosing spondylitis or multiple rib fractures
what are some muscle weakening causes of restrictive disease
intercostal or diaphragmatic e.g. myasthenia gravis, Gullan barre, motor neurone disease and poliomyelitis
what is pathophysiology of DPLD
alveolar barrier to O2 exchange but CO2 exchange unimpaired as alveolar ventilation normal
causes of DPLD caused by fluid in alveolar air space
cardiac pulmonary oedema (raised pulmonary venous pressure) or non-cardiac PO (normal pressure but leaky pulmonary capillaries due to sepsis or trauma)
causes of DPLD caused by consolidation
infective pneumonia, infarction or BOOP (cryptogenic, drugs, rheumatoid disease)
causes of DPLD caused by granulomatous-alveolitis
extrinsic-allergic alveolitis caused by farmers lung and avians,sarcoidosis - caused by lymphadenopathy (presents as rash, uveitis, myocarditis or neuropathy)
causes of DPLD caused by drug induced alveolitis
drugs: amiodarone, bleomycin, methotrexate and gold
causes of DPLD caused by other alveolitis
toxic gases/fumes: chlorinepulmonary fibrosis (scarring)autoimmune: SLE, polyarteritis, wegeners, churg-strauss and bechets
causes of DPLD caused by dust-disease
fibrogenic: asbestos or silicosis non fibrogenic: siderosis (iron), stenosis (tin), baritosis (barium)
causes of DPLD caused by carcinomatosis
due to lymphatics/blood spreadcan also be adenocarcinomatosis e.g. bronchus, breast, prostate, colon or stomach
causes of DPLD caused by eosinophils (type 1/3 allergic response)
drugs: nitrofuratonin fungal: aspergillosis parasites: toxocara, ascaris or filaria autoimmune: charge strauss or polyarteritis
what is the clinical syndrome of DPLD
breathless on exertion, cough but no wheeze, clubbing and central cyanosis, lung crackles, fibrosis at end stage
what is the basic ways to diagnose DPLD
history, reduced lung volume, reduced gas diffusion (DLCO) and arterial oxygen desaturation (reduced PaO2 and SaO2) at rest and exercise
what are the most invasive tests in the diagnosis of DPLD
test for antibody against avian and fungal disease (serum ACE and Ca raised in sarcoid)CXR for bilateral diffuse alveolar infiltrates HRCT to compare inflammatory ground glass and fibrotic nodular component of alveolar infiltrates
what is treatment of DPLD
remove trigger, treat reversible alveolitis (ground glass) by immunosuppressives
what is 1st line drug treatment in DPLD
systemic steroids (oral prednisolone)
what is 2nd line drug treatment in DPLD
oral azathioprine (steroid sparing)
what is treatment for IPF
anti-fibrotic agents: pirfenidone and nintedanib
how is inspiration controlled
pre-botzinger complex excites dorsal neurones, fire in bursts leading to contraction of muscles and when firing stops - passive expiration
how is active expiration (hyperventilation) controlled
increased firing of dorsal excites second group: ventral (located below dorsal) which excites internal intercostals
what is the role of the pons and where is it located
located above dorsal neurones, contains PC whose stimulation (when dorsal neurones fire) terminates inspiration so modify rhythm - without it, prolonged breathing with inspiratory gasps - apneusis
stretch receptors are respiratory centre stimuli; where are they located and what is their role
in walls of bronchi and bronchioles (hering-breur reflex)activated at >1 tidal volumes and may prevent over inflation of lungs during hard exercise
J receptors are respiratory centre stimuli: how are they stimulated?
stimulated by pulmonary capillary congestion, pulmonary oedema and pulmonary emboli